Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0098 | ||||
Gene Name | SLC15A3 | ||||
Protein Name | Peptide/histidine transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | OCTP; Osteoclast transporter; PHT2; PTR3; Peptide transporter 3; Solute carrier family 15 member 3; SLC15A3 | ||||
DT Family | Proton-Dependent Oligopeptide Transporter (POT/PTR) Family ; | ||||
Function | This transporter is proton oligopeptide cotransporter and transports free histidine and certain di- and tripeptides. | ||||
Endogenous Substrate(s) | Dipeptides; Tripeptides | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
L-histidine
|
Phase 2/3 | Drug Info | HARS Syndrome | N.A. | [1] |
References | |||||
1 | Di- and tripeptide transport in vertebrates: the contribution of teleost fish models. J Comp Physiol B. 2017 Apr;187(3):395-462. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.